Antimicrobial Lock Solutions Reduce Catheter-Related Infections in Haemodialysis Patients: Presented at ASN
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Antimicrobial Lock Solutions Reduce Catheter-Related Infections in Haemodialysis Patients: Presented at ASN

By Bryan DeBusk, PhD

SAN FRANCISCO, CA -- November 5, 2007 -- Patients receiving haemodialysis through catheters utilising an antimicrobial lock solution have only about one third the risk of infection compared with dialysis with catheters lacking the solutions, according to a meta-analysis of prospective, randomised, controlled trials.

Michel Jadoul, MD, Head of the Department of Nephrology, Cliniques Universitaires St.-Luc, Brussels, Belgium, reported the findings here at Renal Week 2007, the American Society of Nephrology (ASN) Annual Meeting.

The analysis of eight studies reported between January 1990 and March 2007 examined the incidence of catheter-related bacteraemia (CRB) in 925 patients with 992 catheters and 129,976 catheter-days.

Two hundred twenty-six incidences of CRB were observed over 64,280 catheter-days in patients using a standard heparin lock compared with 77 CRB over 65,696 catheter-days in patients using one of several antimicrobial lock solutions (Relative Risk.353; 95% confidence interval [CI] 0.112-0.411).

Other risk factors -- including presence of diabetes, duration of follow-up, albumin and ferritin levels, proportion of tunnelled catheters, and use of intranasal mupirocin -- did not appear to affect the likelihood of CRB.

Citrate did not confer a benefit over gentamicin or other traditional antibiotics, but gentamicin was better at preventing CRB than other traditional antibiotics (P =.002).

Dr. Jadoul noted that not all haemodialysis centres will see a decrease in CRB with the introduction of antibiotic lock solutions. "Even though the reduction of the risk is impressive, to be honest, it's not sure that everybody should use this. The lower the incidence [of CRB] in your unit, the lower the chance to have a benefit," he said.

Expressing concern about the long-term potential for antibiotic resistance with the use of antimicrobial lock solutions, Dr. Jadoul noted that the use of citrate eliminates potential for resistance and appears to be safe. However, he indicated that long-term observations would be necessary to determine the continued safety and efficacy of all antimicrobial lock solutions.

[Presentation Title: Preventing Hemodialysis Catheter-Related Bacteraemia With an Antimicrobial Lock Solution: A Meta-Analysis of Prospective Randomized Trials. Abstract SU-PO668]

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities